Antoni Ribas, MD, PhD

Antoni Ribas, MD, PhD, is professor of Medicine, professor of Surgery and professor of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA), Director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center, Director of the Parker Institute for Cancer Immunotherapy Center at UCLA and Chair of the Melanoma Committee at SWOG. Dr. Ribas is a physician-scientist who conducts laboratory and clinical research in malignant melanoma, focusing on gene engineered T-cells, PD-1 blockade and BRAF targeted therapies. His National Cancer Institute (NCI), State of California and private foundation-supported research laboratory develops models of disease to test new therapeutic options, studies mechanism of action of treatments in patients and the molecular mechanisms of therapy resistance. He is an elected member of the American Society of Clinical Investigation, the recipient of an AACR Richard and Hinda Rosenthal Award and a NCI Outstanding Investigator Award.

• 2001: Hematology/Oncology Fellowship, UCLA School of Medicine
• 1998: Surgical Oncology Fellowship, UCLA School of Medicine
• 1990: Universidad de Barcelona, MD

• 2013: Outstanding Research Award, Society for Melanoma Research; Physician of the Year, Melanoma International Foundation
• 2009: Elected member, American Society of Clinical Investigation (ASCI)
• 2005: Melanoma Research Foundation Junior Researcher Award
• 2001: Hematology/Oncology Fellowship, UCLA School of Medicine
• 2000: American Society of Clinical Oncology (ASCO) Clinical Research Career Development Award; Amgen Oncology Fellow Award, UCLA; Fellow Teaching Award, UCLA
• 1998: Surgical Oncology Fellowship, UCLA School of Medicine
• 1997: Extraordinary Prize and Suma Cum Laude, Doctoral Thesis, Autonomous University of Barcelona